ToxTree: descriptor-based machine learning models for both hERG and
  Nav1.5 cardiotoxicity liability predictions
  Drug-mediated blockade of the voltage-gated potassium channel(hERG) and the
voltage-gated sodium channel (Nav1.5) can lead to severe cardiovascular
complications. This rising concern has been reflected in the drug development
arena, as the frequent emergence of cardiotoxicity from many approved drugs led
to either discontinuing their use or, in some cases, their withdrawal from the
market. Predicting potential hERG and Nav1.5 blockers at the outset of the drug
discovery process can resolve this problem and can, therefore, decrease the
time and expensive cost of developing safe drugs. One fast and cost-effective
approach is to use in silico predictive methods to weed out potential hERG and
Nav1.5 blockers at the early stages of drug development. Here, we introduce two
robust 2D descriptor-based QSAR predictive models for both hERG and Nav1.5
liability predictions. The machine learning models were trained for both
regression, predicting the potency value of a drug, and multiclass
classification at three different potency cut-offs (i.e. 1$\mu$M, 10$\mu$M, and
30$\mu$M), where ToxTree-hERG Classifier, a pipeline of Random Forest models,
was trained on a large curated dataset of 8380 unique molecular compounds.
Whereas ToxTree-Nav1.5 Classifier, a pipeline of kernelized SVM models, was
trained on a large manually curated set of 1550 unique compounds retrieved from
both ChEMBL and PubChem publicly available bioactivity databases. The proposed
hERG inducer outperformed most metrics of the state-of-the-art published model
and other existing tools. Additionally, we are introducing the first Nav1.5
liability predictive model achieving a Q4 = 74.9% and a binary classification
of Q2 = 86.7% with MCC = 71.2% evaluated on an external test set of 173 unique
compounds. The curated datasets used in this project are made publicly
available to the research community.
